ACHFF (Arch Biopartners) Common Stock: $15.95 Mil (As of Mar. 2026)


ACHFF Arch Biopartners Inc ACHFF
26 GF Score
Price $0.55
! 4 Warning Signs
View Full Analysis

What is Arch Biopartners Common Stock?

Arch Biopartners ACHFF -1.81% 26 Common Stock is $15.95 Mil as of Mar. 2026. GuruFocus rates ACHFF with a GF Score™ of 26/100. The stock has 4 warning signs investors should review.

Arch Biopartners's quarterly common stock increased from Sep. 2025 ($14.71 Mil) to Dec. 2025 ($15.52 Mil) and increased from Dec. 2025 ($15.52 Mil) to Mar. 2026 ($15.95 Mil).

Arch Biopartners's annual common stock increased from Sep. 2023 ($11.74 Mil) to Sep. 2024 ($13.48 Mil) and increased from Sep. 2024 ($13.48 Mil) to Sep. 2025 ($14.71 Mil).

Arch Biopartners Common Stock Historical Data

* Premium members only.

The historical data trend for Arch Biopartners's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arch Biopartners Common Stock Chart

Arch Biopartners Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.65 11.66 11.74 13.48 14.71

Arch Biopartners Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.18 14.06 14.71 15.52 15.95
ACHFF
26GF Score
Arch Biopartners Inc ACHFF
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arch Biopartners Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $15.95 Mil mean?
Arch Biopartners (ACHFF) has a Common Stock of $15.95 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Arch Biopartners and its competitors.
Is Arch Biopartners' Common Stock too high?
Arch Biopartners' current Common Stock is $15.95 Mil. Overall, Arch Biopartners has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Arch Biopartners' Common Stock compare to VRTX and REGN?
Arch Biopartners' Common Stock of $15.95 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Arch Biopartners and its competitors. Arch Biopartners's current Common Stock is $15.95 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arch Biopartners stock overvalued right now?
Arch Biopartners (ACHFF) has a current Common Stock of $15.95 Mil. The current Common Stock is $15.95 Mil. Arch Biopartners' overall GF Score™ is 26/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Arch Biopartners (ACHFF), the current Common Stock is $15.95 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arch Biopartners Business Description

Other Exchanges 8HA:GermanyARCH:Canada
Address 545 King Street West, Toronto, ON, CAN, M5V 1M1
Arch Biopartners Inc is a developer of a therapeutic pipeline designed to address acute kidney injury (AKI) and chronic kidney disease (CKD) by targeting inflammation- and toxin-related kidney damage. The group offers mechanism-based treatments, enabling patients suffering from both acute and chronic kidney conditions to benefit from novel, targeted therapies that address unmet medical needs in kidney care.
26GF Score

Get the complete analysis for ACHFF

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.55
Price